Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Astec Industries, Inc.
Astec Industries Reports Fourth Quarter and 2008 Results
March 15th, 2009
Astec Industries, Inc. (NASDAQ:ASTE) reported results for the fourth quarter and for the year ended December 31, 2008. Revenues for 2008 were $974 million and net income for 2008 was $63 million. Net income was $2.80 per diluted share for 2008 compared to $2.53 per diluted share for 2007, for an increase of $0.27, or 11% per diluted share. Revenues for 2008 were $974 million compared with $869 million for 2007, for an increase of 12%. Domestic sales were $621 million for 2008, or 64% of 2008 revenues, compared to domestic sales of $591 million for 2007, or 68% of 2007 revenues. International sales were $353 million for 2008, a 27% increase over 2007, or 36% of 2008...
Source: Pharma Investments, Ventures & Law Weekly (2009-03-15)
|
